相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigating Metalloproteinases MMP-2 and MMP-9 Mechanosensitivity to Feedback Loops Involved in the Regulation of In Vitro Angiogenesis by Endogenous Mechanical Stresses
Minh-Uyen Dao Thi et al.
ACTA BIOTHEORETICA (2012)
Matrix Metalloproteinase-9 Is Associated with Relapse and Prognosis of Patients with Colorectal Cancer
Dake Chu et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion
Xiaoxia Hu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test
S. Wilson et al.
BRITISH JOURNAL OF CANCER (2012)
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
A. M. J. Langers et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
Celena Scheede-Bergdahl et al.
CLINICAL NUTRITION (2012)
The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
Gabor Lakatos et al.
DIGESTIVE DISEASES (2012)
New European Initiatives in Colorectal Cancer Screening: Budapest Declaration
Tibor Wittmann et al.
DIGESTIVE DISEASES (2012)
The Role of Inflammation and Proteinases in Tumor Progression
Laszlo Herszenyi et al.
DIGESTIVE DISEASES (2012)
Effect of the Expression of Matrix Metalloproteases and Their Tissue Inhibitors on Survival of Patients with Resectable Colorectal Cancer
Lucia Gonzalez et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma
Alexandra Fullar et al.
EXPERIMENTAL CELL RESEARCH (2012)
The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
Magdalena Groblewska et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2012)
The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells
Malgorzata Kapral et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
p38α MAPK mediates 17β-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells
Hsi-Hsien Hsu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Low Testosterone Levels and Increased Inflammatory Markers in Patients with Cancer and Relationship with Cachexia
Basil O. Burney et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
被撤回的出版物: Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA (Retracted article. See OCT, 2022)
Jingchun Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines
M. Waheed Roomi et al.
ONCOLOGY REPORTS (2012)
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis
Gabor Lakatos et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
TIMP-2 Fusion Protein with Human Serum Albumin Potentiates Anti-Angiogenesis-Mediated Inhibition of Tumor Growth by Suppressing MMP-2 Expression
Mi-Sook Lee et al.
PLOS ONE (2012)
Control and inhibition analysis of complex formation processes
Takashi Saitou et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2012)
High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection
Byung Soh Min et al.
ONCOLOGY LETTERS (2012)
The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma
Fatemeh Mashhadiabbas et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2012)
An overview of colorectal cancer survival rates and prognosis in Asia
Bijan Moghimi-Dehkordi et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2012)
Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment
Dimitra Bourboulia et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Sergei I. Grivennikov et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Gastric cancer - The role of matrix metalloproteinases in tumor progression
Marta Lukaszewicz-Zajac et al.
CLINICA CHIMICA ACTA (2011)
Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α
Florian Schelter et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer
Z. Cavdar et al.
COLORECTAL DISEASE (2011)
Gene Expression of Vascular Endothelial Growth Factor A, Thymidylate Synthase, and Tissue Inhibitor of Metalloproteinase 3 in Prediction of Response to Bevacizumab Treatment in Colorectal Cancer Patients
Toshiaki Watanabe et al.
DISEASES OF THE COLON & RECTUM (2011)
Regulation of matrix metalloproteinase activity in health and disease
Elin Hadler-Olsen et al.
FEBS JOURNAL (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers
Mary Jo Murnane et al.
HUMAN PATHOLOGY (2011)
Matrilysin-1 (MMP7) Cleaves Galectin-3 and Inhibits Wound Healing in Intestinal Epithelial Cells
Manjula Puthenedam et al.
INFLAMMATORY BOWEL DISEASES (2011)
TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway
Janne P. Kallio et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
Kyung Sook Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Matrix metalloproteinases in health and disease: regulation by melatonin
Snehasikta Swarnakar et al.
JOURNAL OF PINEAL RESEARCH (2011)
Molecular Mechanisms of Metastasis
Dave S. B. Hoon et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Lymphangiogenesis and Hemangiogenesis: Potential Targets for Therapy
Marlys H. Witte et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
The Role of Matrix Metalloproteinases in Intestinal Epithelial Wound Healing During Normal and Inflammatory States
Dana M. Hayden et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer
Vesna V. Dragutinovic et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals
Hans J. Nielsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Matrix Metalloproteinase-9 Is a Prognostic Marker to Predict Survival of Patients Who Underwent Surgery Due to Rectal Carcinoma
Saulius Svagzdys et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significance
Hong-Qi Liu et al.
ONCOLOGY LETTERS (2011)
Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer
Alexandra M. J. Langers et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2011)
Molecular pathways and targets in cancer-related inflammation
Alberto Mantovani et al.
ANNALS OF MEDICINE (2010)
Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition?
Netta Sela-Passwell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
MMP-9 (Gelatinase B) Expression is Associated With Disease-Free Survival and Disease-Specific Survival in Colorectal Cancer Patients
Riyad Bendardaf et al.
CANCER INVESTIGATION (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Inflammation and Immunity in the Tumor Environment
C. Maletzki et al.
DIGESTIVE DISEASES (2010)
Elevated Serum Matrix Metalloproteinase-3 and-7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival
Yi-Chun Yeh et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Matrix Metalloproteinase Inhibitors A Critical Appraisal of Design Principles and Proposed Therapeutic Utility
Gyoergy Dorman et al.
DRUGS (2010)
Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: A prospective validation study
Helgi Birgisson et al.
EUROPEAN JOURNAL OF CANCER (2010)
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome
Soren Astrup Jensen et al.
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
Barbara Mroczko et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator
Florian Schroetzlmair et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature
Marnelli A. Bautista et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies
Bo Peng et al.
MUTAGENESIS (2010)
Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs)
Xun Li et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2010)
A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1
Hans J. Nielsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease
Laura Makitalo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: The significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis
Young Wan Kim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
Dimitra Bourboulia et al.
SEMINARS IN CANCER BIOLOGY (2010)
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme
Sue Wilson et al.
BMC CANCER (2009)
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential
Rita C. S. Figueira et al.
BMC CANCER (2009)
Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy Ready for prime time?
Stanley Zucker et al.
CANCER BIOLOGY & THERAPY (2009)
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Jacqueline Bromberg et al.
CANCER CELL (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Serum levels of matrix metalloproteinase-2 and-9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
Marwan Emara et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
Raquel F. Gerlach et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation
Dora Cavallo-Medved et al.
EXPERIMENTAL CELL RESEARCH (2009)
Matrix Metalloproteinases and Their Tissue Inhibitors as Prognostic Indicators for Diagnostic and Surgical Recurrence in Crohn's Disease
Martin J. Meijer et al.
INFLAMMATORY BOWEL DISEASES (2009)
Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects
Peter McColgan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry
Maria S. Tretiakova et al.
MODERN PATHOLOGY (2009)
Genetic aspects of inflammation and cancer
Georgina L. Hold et al.
BIOCHEMICAL JOURNAL (2008)
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
Laszlo Herszenyi et al.
BMC CANCER (2008)
Imbalance of tissue inhibitors of metalloproteinases (TIMP)-1 and-4 serum levels, in patients with inflammatory bowel disease
Andreas N. Kapsoritakis et al.
BMC GASTROENTEROLOGY (2008)
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
A. M. J. Langers et al.
BRITISH JOURNAL OF CANCER (2008)
Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy
K. Jung
BRITISH JOURNAL OF CANCER (2008)
Evolving role of uPA/uPAR system in human cancers
Kathleen Ass et al.
CANCER TREATMENT REVIEWS (2008)
Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9
Klaus Jung et al.
CLINICAL CHEMISTRY (2008)
Progress in the development of matrix metalloproteinase inhibitors
GuoGang Tu et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers
Laszlo Herszenyi et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Matrix metalloproteinase inhibitors as anticancer agents
Panagiotis A. Konstantinopoulos et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1
Robert Ramer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon
Laszlo Herszenyi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment
Nanna Moller Sorensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Matrix metalloproteinases at cancer tumor-host interface
Agnes Noel et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
MMPs as therapeutic targets - Still a viable option?
Barbara Fingleton
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
William G. Stetler-Stevenson
CANCER AND METASTASIS REVIEWS (2008)
Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer
J. Decock et al.
CLINICAL GENETICS (2008)
Association of matrix metalloproteinase-2 and-9 promoter polymorphisms with colorectal cancer in Chinese
Enping Xu et al.
MOLECULAR CARCINOGENESIS (2007)
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
N. G. Hurst et al.
BRITISH JOURNAL OF CANCER (2007)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer
Li-Li Xing et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Prognostic significance of matrix metalloproteinases-1,-2,-7 and-13 and tissue inhibitors of metalloproteinases-1,-2,-3 and-4 in colorectal cancer
Marja Hilska et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells
R. Ramer et al.
ONCOGENE (2007)
TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid
Nanna M. Sorensen et al.
CLINICAL CANCER RESEARCH (2007)
Clinical implications of matrix metalloproteinase-1,-3,-7,-9,-12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer
Mijung Woo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease
Martin J. W. Meijer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution
Chun-Ying Wu et al.
CLINICAL CANCER RESEARCH (2007)
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis
Laszlo Herszenyi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane?
Anupama Ravi et al.
INFLAMMATORY BOWEL DISEASES (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
Raquel F. Gerlach et al.
CLINICAL BIOCHEMISTRY (2007)
Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence
Antonio Z. Gimeno-Garcia et al.
EUROPEAN JOURNAL OF CANCER (2006)
Role of matrix metalloproteinases in intestinal inflammation
Carlos Medina et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4
Cecilia A. Fernandez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Inflammation, proteases and cancer
LCL van Kempen et al.
EUROPEAN JOURNAL OF CANCER (2006)
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma
ZH Gao et al.
MODERN PATHOLOGY (2006)
Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
CM Overall et al.
NATURE REVIEWS CANCER (2006)
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin
BR Curtis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Profiling markers of prognosis in colorectal cancer
MS Lyall et al.
CLINICAL CANCER RESEARCH (2006)
The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors
JT Peterson
CARDIOVASCULAR RESEARCH (2006)
Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells
HJ Park et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions
M Cattaneo et al.
NEOPLASIA (2005)
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells:: Role of nuclear factor-κB and reactive oxygen species
MJ Park et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Matrix metalloproteinase inhibitors as anticancer therapeutics
F Mannello et al.
CURRENT CANCER DRUG TARGETS (2005)
Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1I (TIMP-1) in tumor progression
W Hornebeck et al.
BIOCHIMIE (2005)
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease
T Kirkegaard et al.
GUT (2004)
Review - Proteases, extracellular matrix, and cancer - A workshop of the path B study section
YA DeClerck et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
TIMPs as multifacial proteins
E Lambert et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer
T Takeuchi et al.
CLINICAL CANCER RESEARCH (2004)
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers
S Curran et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer
R Sharma et al.
ONCOLOGY (2004)
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition - Implications for reversibility of liver fibrosis
FR Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mechanisms of oncogenesis in colon versus rectal cancer
E Kapiteijn et al.
JOURNAL OF PATHOLOGY (2001)
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma
MT Salmela et al.
BRITISH JOURNAL OF CANCER (2001)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
S Zucker et al.
ONCOGENE (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
B von Lampe et al.
GUT (2000)
Proteases in gastrointestinal neoplastic diseases
L Herszényi et al.
CLINICA CHIMICA ACTA (2000)
Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis
A Stallmach et al.
GUT (2000)
分享论文
